Birdshot Chorioretinopathy: Treatment Stabilizes Vision

 – December 18, 2013  –– 

Visual acuity can remain stable in patients with birdshot chorioretinopathy (BSCR) for 10 years or more, a new study shows. Best corrected visual acuity (BCVA) remained stable in patients who received short-term corticosteroid treatment and those who received longer-term treatment with corticosteroids plus an immunosuppressive agent, according to an article published online December 12 in JAMA Ophthalmology. These findings suggest that "with modern treatment approaches, we can preserve visual acuity and visual field in patients with BSCR and even improve the visual field," said Douglas A. Jabs, MD, MBA, Professor and Chair of Ophthalmology at the Icahn School of Medicine at Mount Sinai, who was not involved in the study.
-Dr. Douglas A. Jabs, Professor, Chair, Ophthalmology, Icahn School of Medicine at Mount Sinai
Learn more